Medicine & Health

Recent graduates, and undergraduate students who are close to graduating, can apply to be part of a two-year post-baccalaureate neuroscience program at WashU. Applications are due by March 9.

Washington University in St. Louis has been recognized as a Focused Ultrasound Center of Excellence by the Focused Ultrasound Foundation.

In a new study, WashU Medicine researchers show that vagus nerve stimulation provides substantial, long-lasting relief to some people with the most severe treatment-resistant depression.

In 2025, the WashU community made new discoveries, celebrated new victories and launched new efforts to make the globe safer and healthier. 

A team of WashU researchers has integrated two novel vision-language models that create a potential AI assistant that may help people with cognitive decline cook meals and remain independent.

Researchers at Washington University in St. Louis have investigated how assemblies of molecules called microphases could be a useful target in developing treatments for neurodegenerative disorders.

Researchers at WashU Medicine and their collaborators have created an immune cell atlas of multiple myeloma, a cancer of the bone marrow. The new resource could improve prognosis and guide development of new immunotherapies.

A team led by Yan Yu of Washington University in St. Louis developed a double-pronged approach to fighting antibiotic resistance.

Startups built on WashU discoveries attracted a record $1.7 billion in private-sector investment over the past year, accelerating the commercialization of WashU innovations into life-changing diagnostics, therapeutics and medical devices.

In a new study, WashU Medicine researchers found that widely prescribed drugs such as Ritalin and Adderall don’t affect attention-controlling regions of the brain, as previously thought, but rather act on areas involved in wakefulness and reward.